User login
Henoch-Schönlein Purpura in an Adult Filipino Man: A Case Report and Literature Review
Henoch-Schönlein purpura (HSP) is a systemic leukocytoclastic vasculitis often noted as a skin rash with palpable petechiae or purpura. The rash of HSP usually is accompanied by arthralgia, abdominal pain, and renal disease.1-3 HSP affects children at a rate of 15 cases/100,000 individuals annually4; the disease is believed to occur less frequently in adults, in whom the natural course of the disease is not as well understood. In adults, HSP can be confused with other autoimmune diseases such as systemic lupus erythematous and hypersensitivity vasculitis. We present a case of adult-onset HSP and review the literature.
Case Report
A 43-year-old Filipino man presented with a 2-day history of eruptions on his legs (Figure 1) and right arm that were mildly pruritic and burned. The lesions had been preceded by 2 weeks of severe arthralgia and myalgia. The patient noted he had experienced some low-grade fevers, and he complained of mild upper abdominal pain.
A few months prior to presentation, the patient had undergone a diagnostic workup by gastroenterology for an evaluation of abdominal pain and bright red blood from the rectum. Results of stool sampling noted the presence of white blood cells. He was evaluated with a barium enema; colonoscopy was not performed. He was diagnosed with acute gastroenteritis and prescribed levofloxacin for 7 days. During a visit to his primary care physician a few weeks prior to presentation, the patient had complained of significant arthralgia. The patient denied upper or lower respiratory tract symptoms. He also denied blood in his urine. The patient's medical history included migraines and a glucose-6-phosphate dehydrogenase deficiency. The only medication he took was sumatriptan for his migraines. The patient had no known allergies. He denied taking vitamins or herbal supplements and had no travel history or sick contacts. Results of a physical examination showed the patient had significant difficulty ambulating but otherwise was in no acute distress. His vital signs were within reference range. Multiple, nonblanching, erythematous papules and pustules were noted on both of the patient's legs and on his right arm. No truncal lesions were noted. Two 4-mm punch biopsy specimens were taken from the patient's left leg. Results of the histopathologic evaluation showed leukocytoclastic vasculitis (Figure 2). Results of direct immunofluorescence assays revealed granular staining (3+) of the superficial blood vessels focally for immunoglobulin A (IgA)(Figure 3). Results of a wound culture were negative. Laboratory examination results are listed in the Table. Results of a urinalysis revealed no protein, casts, or blood. Test results were negative for rheumatoid factor, hepatitis B and C, purified protein derivatives, extractable nuclear antigen antibodies, rapid plasma reagins, human immunodeficiency virus, cryoglobulins, antineutrophil cytoplasmic antibodies, and antinuclear antibodies; results of a throat culture were negative for β-hemolytic streptococcus. The results of a chest x-ray did not reveal abnormalities. The patient was diagnosed with HSP.
The patient was evaluated by the departments of internal medicine, rheumatology, nephrology, and gastroenterology. The patient initially was prescribed a therapeutic regimen of bed rest, acetaminophen, ranitidine, and diphenhydramine. He continued to have recurrent skin eruptions and developed more significant arthralgia and abdominal pain. The patient was given one dose of intramuscular methylprednisolone and oral prednisone. He continued to have occasional skin lesions and mild arthralgias for a few months but currently is clear and has no residual findings.
Comment
HSP predominantly affects people younger than 20 years, and half of all affected children are younger than 5 years.1 The tetrad of rash, arthralgia, abdominal pain, and renal disease can occur in any order over any time period,1-3 and all 4 symptoms do not have to be present clinically. The rash can occur anywhere on the body but usually appears symmetrically on the lower extremities as red to purple lesions. The rash typically presents with palpable petechiae or purpura but has been noted to occur with pustules, vesicles, and bullae. Additionally, the rash can be urticarial, and the Köbner phenomenon can be present. HSP can be distinguished from other autoimmune processes by skin or kidney biopsy results that show IgA deposition. If a biopsy of a skin specimen is performed, immune complexes are found almost equally in the normal-appearing skin and in the lesions of the rash.5 Serum complement levels also can be elevated in patients with HSP. Kawana and Nishiyama6 noted that increased levels of serum C5b-9 could be correlated with increased activity of HSP; however, C3, C4, and CH50 levels should not be monitored because they were not shown to be elevated consistently in HSP and thus were not reliable.6 Gastrointestinal tract lesions have been seen when there is no evidence of characteristic skin findings7-10; the lesions usually are present in the stomach, descending duodenum, and colon.7,11,12 The lesions can be raised, erythematous, or intermittently spaced.10
In several reports, occult bleeding was seen in 50% of the patients with HSP, and 25% of the patients had visible bleeding.7,9,11-13 Endoscopy can be recommended for individuals with suspected HSP because the test may reveal gastrointestinal tract findings that appear without the classic rash.7,9 Renal involvement is common in patients with HSP. Hematuria with or without proteinuria is present in 30% to 70% of patients with HSP. Levy et al14 estimated that HSP nephritis is responsible for 15% of all glomerulopathies in children. A retrospective study by García-Porrúa et al15 noted that hematuria at the onset of HSP with persistence of the renal manifestations during the course of the disease, as well as anemia at disease onset (hemoglobin level <11 g/dL), onset in summer, and relapse, were positive useful predictors for renal sequelae in the adult patients. If a renal biopsy is performed, the percentage of glomeruli showing crescent formation can be correlated with outcome as well. It has been noted that patients with crescents in more than half of the glomeruli are more likely to progress to end-stage or chronic renal disease.16
The erythrocyte sedimentation rate also can be elevated in patients with HSP. Blanco et al17 believed that when comparing adults with children, an elevated erythrocyte sedimentation rate and joint pain more often were found in the adult population, whereas the children had a greater occurrence of abdominal pain, fever, and a preceding upper respiratory tract infection, usually with group A streptococci.
As mentioned previously, HSP easily can be confused with other autoimmune diseases. Thus, the condition should be confirmed with a biopsy specimen from the affected area, which would show leukocytoclastic vasculitis and IgA deposition in the skin or kidney under immunofluorescence microscopy. In many cases, patients with HSP have a history of infection that precedes the symptoms by a few days to 2 weeks. These antecedent infections include streptococcal pharyngitis, viral pharyngitis, sinusitis, urinary tract infection, bronchitis, and diverticulitis.18 Hepatitis B also has been implicated as a cause of HSP.19-21
In a retrospective study comparing the clinical course of patients with HSP who were older than 20 years (adults) with those who were younger than 20 years (children), it was noted that the adults had renal involvement more frequently than the children, with 85% of the adults having a nephropathy versus 25% of the children.17 Of those patients with a nephropathy, the adults developed nephrotic syndrome more often than did the children (13% vs 3%, respectively). Additionally, 13% of the adults with HSP subsequently developed renal insufficiency; however, none of the children with HSP developed this complication. Corticosteroids were given for unresponsive lesions or nephritic involvement. Therapy was required by 63% of the adults and approximately 40% of the children, but 22% of the adults and none of the children needed cytotoxic drugs.17
The overall outcome is favorable in most patients diagnosed with HSP; one study showed a complete recovery in 89% of the adults and 94% of the children with this condition.17 Significant morbidity, however, was seen in a retrospective study of 250 patients aged 15 to 86 years who had enough renal involvement from HSP to require a biopsy. After 15 years, 11% of the patients were dependent on dialysis, and 13% had severe renal failure.22 In rare cases, patients with adult-onset HSP had fatal complications because of arrhythmia from vasculitis, which affected the right atrium, and because of massive pulmonary hemorrhage secondary to extensive petechial bleeding, which was refractory to intravenous steroids.23 Recurrences of HSP tend to be less severe than the original outbreak and usually happen within 4 months of the original symptoms. In children, HSP recurrences have been noted in approximately 33% of patients3,14 and seem to be more likely in the subset of patients with nephritis.3
Most patients do not receive therapy; however, those patients with a higher percentage of crescent formation in the kidneys usually require treatment. Renal transplantation also is an option for patients with HSP with end-stage renal disease, but recurrence is seen after 5 years posttransplantation in 35% of patients.24
In summary, our patient was diagnosed with HSP based on the results of a biopsy, direct immunofluorescence, and laboratory workup. His gastrointestinal tract symptoms are resolved, and he continues to have normal urinalysis results and blood chemistries levels within reference range. He occasionally notes a few new skin lesions and has episodes of mild arthralgia. The patient will continue to be followed up closely to ensure that he does not develop renal abnormalities.
- Meadow SR, Scott DG. Berger disease: Henoch-Schönlein syndrome without a rash. J Pediatr. 1985;106:27-32.
- Cameron JS. Henoch-Schönlein purpura: clinical presentation. Contrib Nephrol. 1984;40:246-249.
- Saulsbury FT. Henoch-Schonlein purpura in children. report of 100 patients and review of the literature. Medicine (Baltimore). 1999;78:395-409.
- Nielsen HE. Epidemiology of Schonlein-Henoch purpura. Acta Paediatr Scand. 1988;77:125-131.
- Van Hale NM, Gibson LE, Schroeter AL. Henoch-Schonlein vasculitis: direct immunofluorescence study of uninvolved skin. J Am Acad Dermatol. 1986;15:665-670.
- Kawana S, Nishiyama S. Serum SC5b-9 (terminal complement complex) level, a sensitive indicator of disease activity in patients with Henoch-Schonlein purpura. Dermatology. 1992;184:171-176.
- Wu CS, Tung SY. Henoch-Schonlein purpura complicated by upper gastrointestinal bleeding with an unusual endoscopic picture. J Clin Gastroenterol. 1994;19:128-131.
- Nathan K, Gunasekaran TS, Berman JH. Recurrent gastrointestinal Henoch-Schonlein purpura. J Clin Gastroenterol. 1999;29:86-89.
- Gunasekaran TS, Berman J, Gonzalaz M. Duodenojejunitis: is it idiopathic or is it Henoch-Schonlein purpura without the purpura? J Pediatr Gastroenterol Nutr. 2000;30:22-28.
- Gunasekeran TS. Henoch-Schonlein purpura: what does the "rash" look like in the gastrointestinal mucosa? Pediatr Dermatol. 1997;14:437-440.
- Nakasone H, Hokama A, Fukuchi J, et al. Colonoscopic findings in an adult patient with Henoch-Schonlein purpura. Gastrointest Endosc. 2000;52:392.
- Yoshikawa N, Yamamura F, Akita Y, et al. Gastrointestinal lesions in an adult patient with Henoch-Schonlein purpura. Hepatogastroenterology. 1999;46:2823-2824.
- Cappell MS, Gupta AM. Colonic lesions associated with Henoch-Schonlein purpura. Am J Gastroenterol. 1990;85:1186-1188.
- Levy M, Broyer M, Arsan A, et al. Anaphylactoid purpura nephritis in childhood: natural history and immunopathology. Adv Nephrol Necker Hosp. 1976;6:183-228.
- García-Porrúa C, González-Louzao C, Llorca J, et al. Predictive factors for renal sequelae in adults with Henoch-Schönlein purpura. J Rheumatol. 2001;28:1019-1024.
- Habib R, Niaudet P, Levy M. Schönlein-Henoch purpura nephritis and IgA nephropathy. In: Tisher CC, Brenner BM, eds. Renal Pathology With Clinical and Functional Correlations. Philadelphia, Pa: Lippincott; 1994:472-523.
- Blanco R, Martinez-Taboada VM, Rodriguez-Valverde V, et al. Henoch-Schönlein purpura in adulthood and childhood: two different expressions of the same syndrome. Arthritis Rheum. 1997;40:859-864.
- Magro CM, Crowson AN. A clinical and histologic study of 37 cases of immunoglobulin A-associated vasculitis. Am J Dermatopathol. 1999;21:234-240.
- Chave T, Neal C, Camp R. Henoch-Schonlein purpura following hepatitis B vaccination. J Dermatolog Treat. 2003;14:179-181.
- Braun S, Ra
Henoch-Schönlein purpura (HSP) is a systemic leukocytoclastic vasculitis often noted as a skin rash with palpable petechiae or purpura. The rash of HSP usually is accompanied by arthralgia, abdominal pain, and renal disease.1-3 HSP affects children at a rate of 15 cases/100,000 individuals annually4; the disease is believed to occur less frequently in adults, in whom the natural course of the disease is not as well understood. In adults, HSP can be confused with other autoimmune diseases such as systemic lupus erythematous and hypersensitivity vasculitis. We present a case of adult-onset HSP and review the literature.
Case Report
A 43-year-old Filipino man presented with a 2-day history of eruptions on his legs (Figure 1) and right arm that were mildly pruritic and burned. The lesions had been preceded by 2 weeks of severe arthralgia and myalgia. The patient noted he had experienced some low-grade fevers, and he complained of mild upper abdominal pain.
A few months prior to presentation, the patient had undergone a diagnostic workup by gastroenterology for an evaluation of abdominal pain and bright red blood from the rectum. Results of stool sampling noted the presence of white blood cells. He was evaluated with a barium enema; colonoscopy was not performed. He was diagnosed with acute gastroenteritis and prescribed levofloxacin for 7 days. During a visit to his primary care physician a few weeks prior to presentation, the patient had complained of significant arthralgia. The patient denied upper or lower respiratory tract symptoms. He also denied blood in his urine. The patient's medical history included migraines and a glucose-6-phosphate dehydrogenase deficiency. The only medication he took was sumatriptan for his migraines. The patient had no known allergies. He denied taking vitamins or herbal supplements and had no travel history or sick contacts. Results of a physical examination showed the patient had significant difficulty ambulating but otherwise was in no acute distress. His vital signs were within reference range. Multiple, nonblanching, erythematous papules and pustules were noted on both of the patient's legs and on his right arm. No truncal lesions were noted. Two 4-mm punch biopsy specimens were taken from the patient's left leg. Results of the histopathologic evaluation showed leukocytoclastic vasculitis (Figure 2). Results of direct immunofluorescence assays revealed granular staining (3+) of the superficial blood vessels focally for immunoglobulin A (IgA)(Figure 3). Results of a wound culture were negative. Laboratory examination results are listed in the Table. Results of a urinalysis revealed no protein, casts, or blood. Test results were negative for rheumatoid factor, hepatitis B and C, purified protein derivatives, extractable nuclear antigen antibodies, rapid plasma reagins, human immunodeficiency virus, cryoglobulins, antineutrophil cytoplasmic antibodies, and antinuclear antibodies; results of a throat culture were negative for β-hemolytic streptococcus. The results of a chest x-ray did not reveal abnormalities. The patient was diagnosed with HSP.
The patient was evaluated by the departments of internal medicine, rheumatology, nephrology, and gastroenterology. The patient initially was prescribed a therapeutic regimen of bed rest, acetaminophen, ranitidine, and diphenhydramine. He continued to have recurrent skin eruptions and developed more significant arthralgia and abdominal pain. The patient was given one dose of intramuscular methylprednisolone and oral prednisone. He continued to have occasional skin lesions and mild arthralgias for a few months but currently is clear and has no residual findings.
Comment
HSP predominantly affects people younger than 20 years, and half of all affected children are younger than 5 years.1 The tetrad of rash, arthralgia, abdominal pain, and renal disease can occur in any order over any time period,1-3 and all 4 symptoms do not have to be present clinically. The rash can occur anywhere on the body but usually appears symmetrically on the lower extremities as red to purple lesions. The rash typically presents with palpable petechiae or purpura but has been noted to occur with pustules, vesicles, and bullae. Additionally, the rash can be urticarial, and the Köbner phenomenon can be present. HSP can be distinguished from other autoimmune processes by skin or kidney biopsy results that show IgA deposition. If a biopsy of a skin specimen is performed, immune complexes are found almost equally in the normal-appearing skin and in the lesions of the rash.5 Serum complement levels also can be elevated in patients with HSP. Kawana and Nishiyama6 noted that increased levels of serum C5b-9 could be correlated with increased activity of HSP; however, C3, C4, and CH50 levels should not be monitored because they were not shown to be elevated consistently in HSP and thus were not reliable.6 Gastrointestinal tract lesions have been seen when there is no evidence of characteristic skin findings7-10; the lesions usually are present in the stomach, descending duodenum, and colon.7,11,12 The lesions can be raised, erythematous, or intermittently spaced.10
In several reports, occult bleeding was seen in 50% of the patients with HSP, and 25% of the patients had visible bleeding.7,9,11-13 Endoscopy can be recommended for individuals with suspected HSP because the test may reveal gastrointestinal tract findings that appear without the classic rash.7,9 Renal involvement is common in patients with HSP. Hematuria with or without proteinuria is present in 30% to 70% of patients with HSP. Levy et al14 estimated that HSP nephritis is responsible for 15% of all glomerulopathies in children. A retrospective study by García-Porrúa et al15 noted that hematuria at the onset of HSP with persistence of the renal manifestations during the course of the disease, as well as anemia at disease onset (hemoglobin level <11 g/dL), onset in summer, and relapse, were positive useful predictors for renal sequelae in the adult patients. If a renal biopsy is performed, the percentage of glomeruli showing crescent formation can be correlated with outcome as well. It has been noted that patients with crescents in more than half of the glomeruli are more likely to progress to end-stage or chronic renal disease.16
The erythrocyte sedimentation rate also can be elevated in patients with HSP. Blanco et al17 believed that when comparing adults with children, an elevated erythrocyte sedimentation rate and joint pain more often were found in the adult population, whereas the children had a greater occurrence of abdominal pain, fever, and a preceding upper respiratory tract infection, usually with group A streptococci.
As mentioned previously, HSP easily can be confused with other autoimmune diseases. Thus, the condition should be confirmed with a biopsy specimen from the affected area, which would show leukocytoclastic vasculitis and IgA deposition in the skin or kidney under immunofluorescence microscopy. In many cases, patients with HSP have a history of infection that precedes the symptoms by a few days to 2 weeks. These antecedent infections include streptococcal pharyngitis, viral pharyngitis, sinusitis, urinary tract infection, bronchitis, and diverticulitis.18 Hepatitis B also has been implicated as a cause of HSP.19-21
In a retrospective study comparing the clinical course of patients with HSP who were older than 20 years (adults) with those who were younger than 20 years (children), it was noted that the adults had renal involvement more frequently than the children, with 85% of the adults having a nephropathy versus 25% of the children.17 Of those patients with a nephropathy, the adults developed nephrotic syndrome more often than did the children (13% vs 3%, respectively). Additionally, 13% of the adults with HSP subsequently developed renal insufficiency; however, none of the children with HSP developed this complication. Corticosteroids were given for unresponsive lesions or nephritic involvement. Therapy was required by 63% of the adults and approximately 40% of the children, but 22% of the adults and none of the children needed cytotoxic drugs.17
The overall outcome is favorable in most patients diagnosed with HSP; one study showed a complete recovery in 89% of the adults and 94% of the children with this condition.17 Significant morbidity, however, was seen in a retrospective study of 250 patients aged 15 to 86 years who had enough renal involvement from HSP to require a biopsy. After 15 years, 11% of the patients were dependent on dialysis, and 13% had severe renal failure.22 In rare cases, patients with adult-onset HSP had fatal complications because of arrhythmia from vasculitis, which affected the right atrium, and because of massive pulmonary hemorrhage secondary to extensive petechial bleeding, which was refractory to intravenous steroids.23 Recurrences of HSP tend to be less severe than the original outbreak and usually happen within 4 months of the original symptoms. In children, HSP recurrences have been noted in approximately 33% of patients3,14 and seem to be more likely in the subset of patients with nephritis.3
Most patients do not receive therapy; however, those patients with a higher percentage of crescent formation in the kidneys usually require treatment. Renal transplantation also is an option for patients with HSP with end-stage renal disease, but recurrence is seen after 5 years posttransplantation in 35% of patients.24
In summary, our patient was diagnosed with HSP based on the results of a biopsy, direct immunofluorescence, and laboratory workup. His gastrointestinal tract symptoms are resolved, and he continues to have normal urinalysis results and blood chemistries levels within reference range. He occasionally notes a few new skin lesions and has episodes of mild arthralgia. The patient will continue to be followed up closely to ensure that he does not develop renal abnormalities.
Henoch-Schönlein purpura (HSP) is a systemic leukocytoclastic vasculitis often noted as a skin rash with palpable petechiae or purpura. The rash of HSP usually is accompanied by arthralgia, abdominal pain, and renal disease.1-3 HSP affects children at a rate of 15 cases/100,000 individuals annually4; the disease is believed to occur less frequently in adults, in whom the natural course of the disease is not as well understood. In adults, HSP can be confused with other autoimmune diseases such as systemic lupus erythematous and hypersensitivity vasculitis. We present a case of adult-onset HSP and review the literature.
Case Report
A 43-year-old Filipino man presented with a 2-day history of eruptions on his legs (Figure 1) and right arm that were mildly pruritic and burned. The lesions had been preceded by 2 weeks of severe arthralgia and myalgia. The patient noted he had experienced some low-grade fevers, and he complained of mild upper abdominal pain.
A few months prior to presentation, the patient had undergone a diagnostic workup by gastroenterology for an evaluation of abdominal pain and bright red blood from the rectum. Results of stool sampling noted the presence of white blood cells. He was evaluated with a barium enema; colonoscopy was not performed. He was diagnosed with acute gastroenteritis and prescribed levofloxacin for 7 days. During a visit to his primary care physician a few weeks prior to presentation, the patient had complained of significant arthralgia. The patient denied upper or lower respiratory tract symptoms. He also denied blood in his urine. The patient's medical history included migraines and a glucose-6-phosphate dehydrogenase deficiency. The only medication he took was sumatriptan for his migraines. The patient had no known allergies. He denied taking vitamins or herbal supplements and had no travel history or sick contacts. Results of a physical examination showed the patient had significant difficulty ambulating but otherwise was in no acute distress. His vital signs were within reference range. Multiple, nonblanching, erythematous papules and pustules were noted on both of the patient's legs and on his right arm. No truncal lesions were noted. Two 4-mm punch biopsy specimens were taken from the patient's left leg. Results of the histopathologic evaluation showed leukocytoclastic vasculitis (Figure 2). Results of direct immunofluorescence assays revealed granular staining (3+) of the superficial blood vessels focally for immunoglobulin A (IgA)(Figure 3). Results of a wound culture were negative. Laboratory examination results are listed in the Table. Results of a urinalysis revealed no protein, casts, or blood. Test results were negative for rheumatoid factor, hepatitis B and C, purified protein derivatives, extractable nuclear antigen antibodies, rapid plasma reagins, human immunodeficiency virus, cryoglobulins, antineutrophil cytoplasmic antibodies, and antinuclear antibodies; results of a throat culture were negative for β-hemolytic streptococcus. The results of a chest x-ray did not reveal abnormalities. The patient was diagnosed with HSP.
The patient was evaluated by the departments of internal medicine, rheumatology, nephrology, and gastroenterology. The patient initially was prescribed a therapeutic regimen of bed rest, acetaminophen, ranitidine, and diphenhydramine. He continued to have recurrent skin eruptions and developed more significant arthralgia and abdominal pain. The patient was given one dose of intramuscular methylprednisolone and oral prednisone. He continued to have occasional skin lesions and mild arthralgias for a few months but currently is clear and has no residual findings.
Comment
HSP predominantly affects people younger than 20 years, and half of all affected children are younger than 5 years.1 The tetrad of rash, arthralgia, abdominal pain, and renal disease can occur in any order over any time period,1-3 and all 4 symptoms do not have to be present clinically. The rash can occur anywhere on the body but usually appears symmetrically on the lower extremities as red to purple lesions. The rash typically presents with palpable petechiae or purpura but has been noted to occur with pustules, vesicles, and bullae. Additionally, the rash can be urticarial, and the Köbner phenomenon can be present. HSP can be distinguished from other autoimmune processes by skin or kidney biopsy results that show IgA deposition. If a biopsy of a skin specimen is performed, immune complexes are found almost equally in the normal-appearing skin and in the lesions of the rash.5 Serum complement levels also can be elevated in patients with HSP. Kawana and Nishiyama6 noted that increased levels of serum C5b-9 could be correlated with increased activity of HSP; however, C3, C4, and CH50 levels should not be monitored because they were not shown to be elevated consistently in HSP and thus were not reliable.6 Gastrointestinal tract lesions have been seen when there is no evidence of characteristic skin findings7-10; the lesions usually are present in the stomach, descending duodenum, and colon.7,11,12 The lesions can be raised, erythematous, or intermittently spaced.10
In several reports, occult bleeding was seen in 50% of the patients with HSP, and 25% of the patients had visible bleeding.7,9,11-13 Endoscopy can be recommended for individuals with suspected HSP because the test may reveal gastrointestinal tract findings that appear without the classic rash.7,9 Renal involvement is common in patients with HSP. Hematuria with or without proteinuria is present in 30% to 70% of patients with HSP. Levy et al14 estimated that HSP nephritis is responsible for 15% of all glomerulopathies in children. A retrospective study by García-Porrúa et al15 noted that hematuria at the onset of HSP with persistence of the renal manifestations during the course of the disease, as well as anemia at disease onset (hemoglobin level <11 g/dL), onset in summer, and relapse, were positive useful predictors for renal sequelae in the adult patients. If a renal biopsy is performed, the percentage of glomeruli showing crescent formation can be correlated with outcome as well. It has been noted that patients with crescents in more than half of the glomeruli are more likely to progress to end-stage or chronic renal disease.16
The erythrocyte sedimentation rate also can be elevated in patients with HSP. Blanco et al17 believed that when comparing adults with children, an elevated erythrocyte sedimentation rate and joint pain more often were found in the adult population, whereas the children had a greater occurrence of abdominal pain, fever, and a preceding upper respiratory tract infection, usually with group A streptococci.
As mentioned previously, HSP easily can be confused with other autoimmune diseases. Thus, the condition should be confirmed with a biopsy specimen from the affected area, which would show leukocytoclastic vasculitis and IgA deposition in the skin or kidney under immunofluorescence microscopy. In many cases, patients with HSP have a history of infection that precedes the symptoms by a few days to 2 weeks. These antecedent infections include streptococcal pharyngitis, viral pharyngitis, sinusitis, urinary tract infection, bronchitis, and diverticulitis.18 Hepatitis B also has been implicated as a cause of HSP.19-21
In a retrospective study comparing the clinical course of patients with HSP who were older than 20 years (adults) with those who were younger than 20 years (children), it was noted that the adults had renal involvement more frequently than the children, with 85% of the adults having a nephropathy versus 25% of the children.17 Of those patients with a nephropathy, the adults developed nephrotic syndrome more often than did the children (13% vs 3%, respectively). Additionally, 13% of the adults with HSP subsequently developed renal insufficiency; however, none of the children with HSP developed this complication. Corticosteroids were given for unresponsive lesions or nephritic involvement. Therapy was required by 63% of the adults and approximately 40% of the children, but 22% of the adults and none of the children needed cytotoxic drugs.17
The overall outcome is favorable in most patients diagnosed with HSP; one study showed a complete recovery in 89% of the adults and 94% of the children with this condition.17 Significant morbidity, however, was seen in a retrospective study of 250 patients aged 15 to 86 years who had enough renal involvement from HSP to require a biopsy. After 15 years, 11% of the patients were dependent on dialysis, and 13% had severe renal failure.22 In rare cases, patients with adult-onset HSP had fatal complications because of arrhythmia from vasculitis, which affected the right atrium, and because of massive pulmonary hemorrhage secondary to extensive petechial bleeding, which was refractory to intravenous steroids.23 Recurrences of HSP tend to be less severe than the original outbreak and usually happen within 4 months of the original symptoms. In children, HSP recurrences have been noted in approximately 33% of patients3,14 and seem to be more likely in the subset of patients with nephritis.3
Most patients do not receive therapy; however, those patients with a higher percentage of crescent formation in the kidneys usually require treatment. Renal transplantation also is an option for patients with HSP with end-stage renal disease, but recurrence is seen after 5 years posttransplantation in 35% of patients.24
In summary, our patient was diagnosed with HSP based on the results of a biopsy, direct immunofluorescence, and laboratory workup. His gastrointestinal tract symptoms are resolved, and he continues to have normal urinalysis results and blood chemistries levels within reference range. He occasionally notes a few new skin lesions and has episodes of mild arthralgia. The patient will continue to be followed up closely to ensure that he does not develop renal abnormalities.
- Meadow SR, Scott DG. Berger disease: Henoch-Schönlein syndrome without a rash. J Pediatr. 1985;106:27-32.
- Cameron JS. Henoch-Schönlein purpura: clinical presentation. Contrib Nephrol. 1984;40:246-249.
- Saulsbury FT. Henoch-Schonlein purpura in children. report of 100 patients and review of the literature. Medicine (Baltimore). 1999;78:395-409.
- Nielsen HE. Epidemiology of Schonlein-Henoch purpura. Acta Paediatr Scand. 1988;77:125-131.
- Van Hale NM, Gibson LE, Schroeter AL. Henoch-Schonlein vasculitis: direct immunofluorescence study of uninvolved skin. J Am Acad Dermatol. 1986;15:665-670.
- Kawana S, Nishiyama S. Serum SC5b-9 (terminal complement complex) level, a sensitive indicator of disease activity in patients with Henoch-Schonlein purpura. Dermatology. 1992;184:171-176.
- Wu CS, Tung SY. Henoch-Schonlein purpura complicated by upper gastrointestinal bleeding with an unusual endoscopic picture. J Clin Gastroenterol. 1994;19:128-131.
- Nathan K, Gunasekaran TS, Berman JH. Recurrent gastrointestinal Henoch-Schonlein purpura. J Clin Gastroenterol. 1999;29:86-89.
- Gunasekaran TS, Berman J, Gonzalaz M. Duodenojejunitis: is it idiopathic or is it Henoch-Schonlein purpura without the purpura? J Pediatr Gastroenterol Nutr. 2000;30:22-28.
- Gunasekeran TS. Henoch-Schonlein purpura: what does the "rash" look like in the gastrointestinal mucosa? Pediatr Dermatol. 1997;14:437-440.
- Nakasone H, Hokama A, Fukuchi J, et al. Colonoscopic findings in an adult patient with Henoch-Schonlein purpura. Gastrointest Endosc. 2000;52:392.
- Yoshikawa N, Yamamura F, Akita Y, et al. Gastrointestinal lesions in an adult patient with Henoch-Schonlein purpura. Hepatogastroenterology. 1999;46:2823-2824.
- Cappell MS, Gupta AM. Colonic lesions associated with Henoch-Schonlein purpura. Am J Gastroenterol. 1990;85:1186-1188.
- Levy M, Broyer M, Arsan A, et al. Anaphylactoid purpura nephritis in childhood: natural history and immunopathology. Adv Nephrol Necker Hosp. 1976;6:183-228.
- García-Porrúa C, González-Louzao C, Llorca J, et al. Predictive factors for renal sequelae in adults with Henoch-Schönlein purpura. J Rheumatol. 2001;28:1019-1024.
- Habib R, Niaudet P, Levy M. Schönlein-Henoch purpura nephritis and IgA nephropathy. In: Tisher CC, Brenner BM, eds. Renal Pathology With Clinical and Functional Correlations. Philadelphia, Pa: Lippincott; 1994:472-523.
- Blanco R, Martinez-Taboada VM, Rodriguez-Valverde V, et al. Henoch-Schönlein purpura in adulthood and childhood: two different expressions of the same syndrome. Arthritis Rheum. 1997;40:859-864.
- Magro CM, Crowson AN. A clinical and histologic study of 37 cases of immunoglobulin A-associated vasculitis. Am J Dermatopathol. 1999;21:234-240.
- Chave T, Neal C, Camp R. Henoch-Schonlein purpura following hepatitis B vaccination. J Dermatolog Treat. 2003;14:179-181.
- Braun S, Ra
- Meadow SR, Scott DG. Berger disease: Henoch-Schönlein syndrome without a rash. J Pediatr. 1985;106:27-32.
- Cameron JS. Henoch-Schönlein purpura: clinical presentation. Contrib Nephrol. 1984;40:246-249.
- Saulsbury FT. Henoch-Schonlein purpura in children. report of 100 patients and review of the literature. Medicine (Baltimore). 1999;78:395-409.
- Nielsen HE. Epidemiology of Schonlein-Henoch purpura. Acta Paediatr Scand. 1988;77:125-131.
- Van Hale NM, Gibson LE, Schroeter AL. Henoch-Schonlein vasculitis: direct immunofluorescence study of uninvolved skin. J Am Acad Dermatol. 1986;15:665-670.
- Kawana S, Nishiyama S. Serum SC5b-9 (terminal complement complex) level, a sensitive indicator of disease activity in patients with Henoch-Schonlein purpura. Dermatology. 1992;184:171-176.
- Wu CS, Tung SY. Henoch-Schonlein purpura complicated by upper gastrointestinal bleeding with an unusual endoscopic picture. J Clin Gastroenterol. 1994;19:128-131.
- Nathan K, Gunasekaran TS, Berman JH. Recurrent gastrointestinal Henoch-Schonlein purpura. J Clin Gastroenterol. 1999;29:86-89.
- Gunasekaran TS, Berman J, Gonzalaz M. Duodenojejunitis: is it idiopathic or is it Henoch-Schonlein purpura without the purpura? J Pediatr Gastroenterol Nutr. 2000;30:22-28.
- Gunasekeran TS. Henoch-Schonlein purpura: what does the "rash" look like in the gastrointestinal mucosa? Pediatr Dermatol. 1997;14:437-440.
- Nakasone H, Hokama A, Fukuchi J, et al. Colonoscopic findings in an adult patient with Henoch-Schonlein purpura. Gastrointest Endosc. 2000;52:392.
- Yoshikawa N, Yamamura F, Akita Y, et al. Gastrointestinal lesions in an adult patient with Henoch-Schonlein purpura. Hepatogastroenterology. 1999;46:2823-2824.
- Cappell MS, Gupta AM. Colonic lesions associated with Henoch-Schonlein purpura. Am J Gastroenterol. 1990;85:1186-1188.
- Levy M, Broyer M, Arsan A, et al. Anaphylactoid purpura nephritis in childhood: natural history and immunopathology. Adv Nephrol Necker Hosp. 1976;6:183-228.
- García-Porrúa C, González-Louzao C, Llorca J, et al. Predictive factors for renal sequelae in adults with Henoch-Schönlein purpura. J Rheumatol. 2001;28:1019-1024.
- Habib R, Niaudet P, Levy M. Schönlein-Henoch purpura nephritis and IgA nephropathy. In: Tisher CC, Brenner BM, eds. Renal Pathology With Clinical and Functional Correlations. Philadelphia, Pa: Lippincott; 1994:472-523.
- Blanco R, Martinez-Taboada VM, Rodriguez-Valverde V, et al. Henoch-Schönlein purpura in adulthood and childhood: two different expressions of the same syndrome. Arthritis Rheum. 1997;40:859-864.
- Magro CM, Crowson AN. A clinical and histologic study of 37 cases of immunoglobulin A-associated vasculitis. Am J Dermatopathol. 1999;21:234-240.
- Chave T, Neal C, Camp R. Henoch-Schonlein purpura following hepatitis B vaccination. J Dermatolog Treat. 2003;14:179-181.
- Braun S, Ra